1. A Family Affair

3. HoFH

9. Prevalence of FH

10. FH Starts Before Birth

11. Genetics in CHD Risk Reduction

12. Lipid-Lowering Therapies

13. Lipid-Lowering Therapy in HoFH CV Outcomes

14. Long-term Outcomes of Lipid-Lowering in FH

15. Lomitapide and Mipomersen

16. Phase 3 Trials Lomitapide and Mipomersen Lipid End Points at Week 26

17. Phase 3 Trials Safety of Lomitapide and Mipomersen

18. Role of Lp(a) in Coronary Disease

20. TESLA Trial Evaluating PCSK9 Antibody in HoFH

21. Take-Home Messages

22. Abbreviations

23. Abbreviations (cont)

24. References

25. References (cont)

26. References (cont)

27. References (cont)

28. References (cont)